It is 2033, and antibiotic resistance is no longer a threat. How did we get there? (Mini Case)
In the early 2000s, addressing antibiotics resistance seemed like an insurmountable threat. The World Health Organization (WHO) projected that it would claim 8–10 million lives annually by 2050 if left unchecked. Antibiotics, long considered a miracle of modern medicine, had, over time, become increasingly ineffective as bacteria evolved mechanisms to resist them. What was once a triumph of science had slowly turned into a global nightmare, and finding the solution to this potential crisis had been as much about fixing economic systems as it was about developing new drugs. The good news is that by 2033, the world has turned the corner and addressed an enormous global health problem. How did we solve it “before we had to?”
- Apply the future-back approach to a real-life global health issue
Healthcare
2024-2033
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
What does a zero target measure? In 2016, Barry Callebaut launched Forever Chocolate with a pledge to eradicate child labor from its supply chain by 2025. For its 2021-22 financial year, the company reported over 25,000 cases of child labor identi...
Holcim is a Swiss multinational company that manufactures cement and building materials. Excluding China, it is the top cement producer in the world. Holcim is also a top 50 CO2 emissions emitter. And it decisively put sustainability efforts front...
Luxury’s approach to sustainability has hit a dead end. In Purposeful Luxury, I show that the top 100 luxury brands have started to conscientiously reduce negative impacts across the three ESG categories. But the results are largely insufficient b...
Sustainability reporting is now common among large companies. According to the OECD, firms representing 91% of global listed market capitalization disclose sustainability-related information. Yet we find that firms with strong reporting often assu...
In a world where climate action often stalls at the policy level, this book spotlights how leading companies are stepping up to reduce CO₂ emissions and improve public health—through innovation, strategy, and bold leadership. From maritime decarbo...
Case reference: IMD-2712 ©2026
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications